Jens Lehmann

1.0k total citations
59 papers, 663 citations indexed

About

Jens Lehmann is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jens Lehmann has authored 59 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 15 papers in Public Health, Environmental and Occupational Health and 14 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jens Lehmann's work include Childhood Cancer Survivors' Quality of Life (14 papers), Cancer survivorship and care (14 papers) and Palliative Care and End-of-Life Issues (10 papers). Jens Lehmann is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (14 papers), Cancer survivorship and care (14 papers) and Palliative Care and End-of-Life Issues (10 papers). Jens Lehmann collaborates with scholars based in Austria, Germany and Australia. Jens Lehmann's co-authors include Bernhard Holzner, JF Bernardet, Gerhard Rumpold, David Riedl, Michael Stöckle, Matthias Ziegler, Tillmann Loch, K. Remberger, Jörn Kamradt and S. Siemer and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and The Journal of Urology.

In The Last Decade

Jens Lehmann

53 papers receiving 638 citations

Peers

Countries citing papers authored by Jens Lehmann

Since Specialization

Citations

This map shows the geographic impact of Jens Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Lehmann more than expected).

Fields of papers citing papers by Jens Lehmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Lehmann. The network helps show where Jens Lehmann may publish in the future.

Co-authorship network of co-authors of Jens Lehmann

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Lehmann. A scholar is included among the top collaborators of Jens Lehmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Lehmann. Jens Lehmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sustainability and Time Trends in Electronic Patient-Reported Outcome Assessment in Routine Cancer Care: Systematic Scoping Review and Follow-Up Survey 2025 ·Journal of Medical Internet Research ·(unknown), (unknown), Kelly M. de Ligt, (unknown), (unknown), Lisa M. Wintner, (unknown), (unknown), Bernhard Holzner, Monika Sztankay, Jens Lehmann	1
2	Implementierung von ePROs in der Onkologie 2025 ·(unknown), (unknown), Daniel Dejaco, Wolfgang Willenbacher, Andreas Meryk, Roman Crazzolara, Reto Bale, (unknown), Gerhard Rumpold, Jens Lehmann, Bernhard Holzner	0
3	Präimplementierung von elektronischen Patientenberichten an Referenzzentren für Kopf-Hals-Onkologie 2025 ·HNO ·Daniel Dejaco, (unknown), (unknown), (unknown), Jens Lehmann, (unknown), Gerhard Rumpold, Bernhard Holzner, (unknown), Benedikt Hofauer	1
4	Evaluating an electronic patient-reported outcome monitoring system in patients with prostate cancer in routine clinical care: a prospective observational study 2025 ·Quality of Life Research ·(unknown), (unknown), Stefanie Kreissl, (unknown), (unknown), (unknown), Bernhard Holzner, Ute Ganswindt, Jens Lehmann	2
5	Adherence to daily electronic symptom screening in pediatric cancer: associations with time, location and pain 2025 ·Quality of Life Research ·(unknown), Andreas Meryk, Johannes M. Giesinger, (unknown), (unknown), (unknown), Gabriele Kropshofer, Benjamin Hetzer, Gerhard Rumpold, Bernhard Holzner, Roman Crazzolara, Jens Lehmann	1
6	Core outcome sets in cancer clinical trials: current status and future opportunities—an EORTC perspective 2025 ·Trials ·(unknown), Steven MacLennan, Jan Bogaerts, Saskia Litière, Vassilis Golfinopoulos, Jens Lehmann, (unknown), Paula Williamson, Mieke Van Hemelrijck	0
7	Danish value sets for the EORTC QLU-C10D utility instrument 2024 ·Quality of Life Research ·Jens Lehmann, (unknown), Morten Aagaard Petersen, Bernhard Holzner, Richard Norman, Madeleine King, Georg Kemmler, (unknown)	7
8	Norwegian and Swedish value sets for the EORTC QLU-C10D utility instrument 2024 ·Quality of Life Research ·Gudrun Rohde, Jens Lehmann, (unknown), (unknown), Bernhard Holzner, Madeleine King, Richard Norman, Georg Kemmler, (unknown)	1
9	Integration of Daily Patient-Reported Outcome Measures in Pediatric Stem Cell Transplantation 2023 ·Transplantation and Cellular Therapy ·Benjamin Hetzer, Andreas Meryk, Gabriele Kropshofer, Christina Salvador, David Riedl, Jens Lehmann, Gerhard Rumpold, (unknown), (unknown), Bernhard Holzner, Roman Crazzolara	3
10	Usability of Electronic Patient-Reported Outcome Measures for Older Patients With Cancer: Secondary Analysis of Data from an Observational Single Center Study 2023 ·Journal of Medical Internet Research ·David Riedl, Jens Lehmann, (unknown), Daniel Dejaco, Vincent Grote, Michael J. Fischer, Gerhard Rumpold, Bernhard Holzner, Thomas Licht	13
11	Adherence to Patient-Reported Symptom Monitoring and Subsequent Clinical Interventions for Patients With Multiple Myeloma in Outpatient Care: Longitudinal Observational Study 2023 ·Journal of Medical Internet Research ·Jens Lehmann, Kelly M. de Ligt, (unknown), Johannes M. Giesinger, Monika Sztankay, (unknown), Lonneke V. van de Poll‐Franse, Gerhard Rumpold, (unknown), Ella Willenbacher, Wolfgang Willenbacher, Bernhard Holzner	6
12	The effect of inflammation, SARS-CoV-2 infection, age and mental health on serotonin, and kynurenine and catecholamine pathway metabolites 2023 ·Psychoneuroendocrinology ·Katharina Hüfner, (unknown), Piotr Tymoszuk, (unknown), (unknown), E Deisenhammer, (unknown), (unknown), Johannes M. Giesinger, Jens Lehmann, (unknown), (unknown), (unknown), Bernhard Holzner, Johanna M. Gostner, Barbara Sperner‐Unterweger	8
13	Disagreement between mothers' and fathers' rating of health-related quality of life in children with cancer 2023 ·Quality of Life Research ·Andreas Meryk, Gabriele Kropshofer, Benjamin Hetzer, David Riedl, Jens Lehmann, Gerhard Rumpold, (unknown), (unknown), Christina Salvador, Evelyn Rabensteiner, (unknown), Bernhard Holzner, Roman Crazzolara	7
14	Associations of Age and Sex with the Efficacy of Inpatient Cancer Rehabilitation: Results from a Longitudinal Observational Study Using Electronic Patient-Reported Outcomes 2023 ·Cancers ·Jens Lehmann, David Riedl, (unknown), (unknown), Marco Hassler, Gerhard Rumpold, Bernhard Holzner, Thomas Licht	4
15	Clinical Outcome Assessment in Cancer Rehabilitation and the Central Role of Patient-Reported Outcomes 2021 ·Cancers ·Jens Lehmann, (unknown), David Riedl, Gerhard Rumpold, Vincent Grote, Michael J. Fischer, Bernhard Holzner	21
16	Using the Computer-based Health Evaluation System (CHES) to Support Self-management of Symptoms and Functional Health: Evaluation of Hematological Patient Use of a Web-Based Patient Portal 2021 ·Journal of Medical Internet Research ·Jens Lehmann, (unknown), Johannes M. Giesinger, Lisa M. Wintner, Monika Sztankay, (unknown), Wolfgang Willenbacher, (unknown), (unknown), Gerhard Rumpold, Bernhard Holzner	16
17	The cancer patient’s perspective of COVID‐19‐induced distress—A cross‐sectional study and a longitudinal comparison of HRQOL assessed before and during the pandemic 2021 ·Cancer Medicine ·Karin A. Koinig, C. Arnold, Jens Lehmann, Johannes M. Giesinger, (unknown), Wolfgang Willenbacher, (unknown), Bernhard Holzner, Ute Ganswindt, Dominik Wolf‎, Reinhard Stauder	29
18	Estimating seroprevalence of SARS-CoV-2 antibodies using three self-reported symptoms: development of a prediction model based on data from Ischgl, Austria 2021 ·Epidemiology and Infection ·Jens Lehmann, Johannes M. Giesinger, Gerhard Rumpold, Wegene Borena, Ludwig Knabl, Barbara Falkensammer, (unknown), (unknown), Dorotheé von Laer, Barbara Sperner‐Unterweger, Bernhard Holzner	2
19	Imaging Studies in Metastatic Urogenital Cancer Patients Undergoing Systemic Therapy: Recommendations of a Multidisciplinary Consensus Meeting of the Association of Urological Oncology of the German Cancer Society 2010 ·Urologia Internationalis ·Axel Heidenreich, Peter Albers, Johannes Claßen, Markus Graefen, (unknown), Jörg Kotzerke, S. Krege, Jens Lehmann, (unknown), Heinz Schmidberger, Michael Uder, Hajo Zeeb	37
20	Nachsorge des Harnblasenkarzinoms 2001 ·Der Urologe ·Margitta Retz, Jens Lehmann, Bernd Wullich, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact